Related Experiment Video

Updated: Jul 19, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Immunotoxin treatment of cancer

Ira Pastan1, Raffit Hassan, David J FitzGerald

  • 1Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. pastani@mail.nih.gov

Annual Review of Medicine
|October 25, 2006
PubMed

Insights

Immunotoxins, engineered proteins combining antibodies and toxins, show promise for cancer treatment by targeting cancer cells. Current research focuses on overcoming challenges in solid tumor therapy.

Area of Science:

  • Oncology
  • Protein Engineering
  • Immunotherapy

Background:

  • Immunotoxins are therapeutic proteins comprising an antibody fragment and a toxin.
  • They target cancer cells by binding to surface antigens, internalizing, and inducing cell death.
  • Bacterial and plant toxins yield the most potent immunotoxins.

Purpose of the Study:

  • To review the development and application of recombinant immunotoxins in cancer therapy.
  • To identify current limitations in treating solid tumors with immunotoxins.
  • To highlight ongoing strategies aimed at overcoming these therapeutic challenges.

Main Methods:

  • Protein engineering techniques are employed to create recombinant immunotoxins.
  • Design of immunotoxins is tailored for specific cancer types.
  • Analysis of treatment outcomes, particularly for hematologic versus solid tumors.

Main Results:

  • Recombinant immunotoxins have demonstrated success, primarily in hematologic malignancies.
  • Significant obstacles hinder effective solid tumor treatment, including poor tumor penetration.
  • Host immune responses to the toxin component limit treatment efficacy and duration.

Conclusions:

  • Immunotoxins represent a promising therapeutic strategy in oncology.
  • Further research and innovative strategies are essential for successful solid tumor treatment.
  • Overcoming immune response and penetration barriers is critical for advancing immunotoxin therapy.

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...